Aging is associated with chronic inflammation (inflamm-aging) partly mediated by increased 21 levels of damage-associated molecular patterns (DAMPs) which activate pattern recognition 22 receptors (PRRs) of the innate immune system. Furthermore, many aging-related disorders are 23 associated with inflammation. PRRs, like Toll-like receptors (TLRs) and NOD-like receptors 24 (NLRs) are not only expressed in cells of the innate immune system, but other cells as well, 25
Introduction
accumulation of neurotoxic serum proteins in the brain tissue contributing to 88 neurodegeneration. 89
Altogether, changes in functions of the microvasculature during aging (i.e. neurovascular 90 uncoupling and alterations in BBB integrity) lead to irreversible neuronal injury. Reductions 91 in brain microcirculation and BBB breakdown may occur prior to neurodegeneration and 92 neuroinflammation, as shown in pericyte-deficient mice However, the exact contribution of 93 microvascular changes to neurodegeneration in aging is not well understood. Nevertheless, 94 endothelial and glial, but not neuronal-specific genes are the best predictors of biological age 95 (132) . Therefore, the "you are as old as your microvessels" statement refers to the direct link 96 between vascular and neuronal injury in aging. 97
Besides endothelial cells and pericytes, astrocytes are also changing during physiological and 98 pathological aging. The total number of astrocytes in the human brain does not change with 99 age (121); however, morphological and metabolic remodeling occurs. These changes might be 100 region specific and might reflect astroglial adaptive plasticity (121) . In astrocytes of aged 101 animals, reduction of gap junction plaques (23), decrease in morphological complexity (32) 102 and reduction in the ability to support survival of motor neurons (28) were described. 103
Moreover, astrocytes having a senescence-associated secretory phenotype (SASP) accumulate 104 with age, showing increased expression of glial fibrillary acidic protein (GFAP) and other 105 intermediate filaments, secretion of inflammatory cytokines, chemokines and proteinases 106 (124) . 107
Other cell types of the NVU (neurons and microglia) also present morphological and 108 functional changes in the elderly (reviewed in: (39)). Moreover, alteration of the structure and 109 function of the NVU is even more accentuated in pathological aging (39) . Unfortunately, 110 hallmarks of aging are only referring to changes in the phenotypes of cells (86, 99) , the 111 relevance of these changes (i.e. causative or reactive role to aging) is largely uncharacterized.
Inflammation and aging-related functional changes of the NVU 113
In parallel with these mechanisms, inflammation is a central element affecting cells of the 114 NVU during aging. Inflammation in the brain has mainly been linked to microglia and to a 115 lower extent to astrocytes. However, other cells of the NVU are also participating in 116 inflammatory responses; therefore, might also be key players in aging processes of the CNS. 117 Vascular inflammation is associated with BBB opening and neurovascular uncoupling, the 118 main aging-related neurovascular dysfunctions. Inflammation is a well-characterized cause of 119 BBB disruption (2, 145) . Mechanisms of BBB opening may include cytokine-induced actin 120 remodeling and modulation of TJ protein levels or subcellular relocalization (19) . In mice, 121 during normal aging, reduced amount of TJ proteins and elevated expression of TNF-α has 122 been observed in CECs, without changes in adhesion molecules and with no leukocyte 123 recruitment (37), suggesting a direct effect of the cytokine on the amount of TJ proteins. In 124 aging-related brain pathologies, like AD or ischemia, increased secretion of inflammatory 125 cytokines in the cerebral endothelium may enhance expression of adhesion molecules as well 126 (57, 123) . Consequent migration of circulating leukocytes through the activated brain 127 endothelium may also contribute to deterioration in barrier properties of the BBB, which is 128 also part of the pathogenesis of these diseases (114, 154) . Besides increased BBB 129 permeability, changes in cerebral blood flow and impaired hemodynamic coupling also occur 130 in response to inflammatory cytokines, like 13) . Moreover, reactive oxygen species 131 Inflammatory vascular dysfunctions not only depend on endothelial but on pericyte-and 137 astrocyte-linked mechanisms as well. Pericytes respond to inflammatory cytokines through 138 enhanced expression of adhesion molecules and secretion of inflammatory mediators (106, 139 111 ). In addition, astrocytes are a common source of inflammatory mediators in brain 140 pathologies (43). 141 Therefore, cells of the NVU can both respond to and release inflammatory mediators, and 142 vascular inflammation seems to be an important step in aging-related functional changes of 143 the NVU. In the next chapters, we describe inflammatory aspects of the aging NVU. 144
Inflammation, damage-associated molecular patterns (DAMPs) and pattern recognition 145

receptors (PRRs) in aging 146
Aging is the greatest risk factor for developing chronic diseases, many of which are directly 147 linked to a persistent low grade inflammation, called inflamm-aging (49). Inflamm-aging is 148 characterized by a pro-inflammatory environment in several tissues, consisting of activation 149 of resident macrophages, leukocyte infiltration and increased production of inflammatory 150 cytokines and ROS. Aging is also associated with the senescence of the immune system, 151 characterized by loss of naïve T cells, accumulation of memory T cells, thymic involution, 152 decline in the total number of phagocytes, impairment of dendritic cells and natural killers, 153 delayed cytokine release, etc. (93, 130), leading to increased frequency of infections and 154 chronic diseases. 155 Inflammation is highly regulated by the immune system, which has two main branches, the 156 innate and the adaptive (acquired) immune system. Initialization of inflammatory processes is 157 largely dependent on the innate immune system. Sensing of potentially dangerous molecules -158 like pathogen-associated molecular patterns (PAMPs) and damage-associated molecular 159 patterns (DAMPs)by the innate immune system depends on pattern recognition receptors 160 (PRRs) consisting of at least four major families (Table 1) . Members of the Toll-like receptor 161 (TLR) and the C-type lectin receptor (CLR) families are membrane-bound PRRs, while 162 retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) and the nucleotide-binding 163 oligomerization domain (NOD)-like receptors (NLRs) detect intracellular patterns (91, 138) . 164
Indeed, PAMPs are the most potent activators of these receptors. However, endogenous 165 molecules released upon tissue damage (DAMPs) can activate the same receptors and 166 signaling pathways driving a sterile inflammatory reaction. The most widely studied DAMPs 167 are heat shock proteins, the chromatin protein high mobility group box-1 (HMGB1), 168 extracellular matrix fragments and purine metabolites, such as ATP and uric acid. DAMP-169 dependent sterile inflammation is key player in aging-related pathologies (47). Moreover, 170
DAMPs were proposed to be biomarkers and interventional targets in aging-associated 171 diseases (70). In elderly, DAMP-induced chronic inflammation is more prevalent than in 172 young individuals. Chronic oxidative stress is a hallmark of aging and reactive oxygen species 173 induce oxidative damage leading to formation of DAMPs (38, 125) . Accumulation of 174 crystalline DAMPs, like urate crystals, cholesterol or amyloid deposits may also increase with 175 age. The most important DAMP-identifying PRRs are TLRs and NLRP3 (47). 176
Inflammasome activation in aging 177
Activation of some NLRs leads to the assembly of inflammasomes, which are large 178 multiprotein complexes mediating activation of inflammatory caspases. The best known 179 inflammasome-forming NLRs are NLRP1, NLRP3 and NLRC4. Besides, other NLRs might 180 also form inflammasomes (e.g. NLRP2, NLRP6, NLRP7 or NLRP12). In addition, non-NLR 181 family members (e.g. AIM2absent in melanoma 2, IFI16 -γ-interferon-inducible protein 182
Upon recognition of inflammatory signals, inflammasome initiators oligomerize, recruit the 184 adaptor protein ASC (apoptosis-associated speck-like protein containing CARD) which 185 interacts with and initiates autoactivation of an inflammatory caspase (caspase-1 or caspase-186 11/4/5). The active caspase processes precursors of inflammatory cytokines, mainly IL-1β or 187 IL-18 (7) and can also initiate pyroptosis (15) . Inflammasomes can play a pivotal role in low-grade chronic inflammation associated with 200 metabolic abnormalities and aging (i.e. inflamm-aging) as well. Moreover, inflammasome 201 activation has been linked to diverse brain diseases (including ischemic and traumatic brain 202 injury and neurodegenerative diseases) and to comorbidities and risk factors of CNS 203 pathologies (e.g. diabetes, atherosclerosis, obesity, hypertension, etc.) (reviewed in: (74)). 204
It is well accepted that NLRP3 inflammasome assembly requires two signals: a priming signal 205 inducing upregulation of the expression of inflammasome components and an activation 206 signal required for the assembly of the inflammasome (58). It has been suggested that, 207 although NLRP3 can be activated by a wide variety of pathogens, its primary role is sensing 208 metabolic disturbance and restoring homeostasis. However, chronic metabolic dysfunction in 209 aging might result in aberrant NLRP3 response, leading to aging-associated inflammatory 210 disorders (21). In the absence of PAMPs, elevated levels of TNF-α (110) seem to be one of 211 the major inducers of NLRP3 expression in macrophages of the liver and in adipose tissue in 212 aged mice (8). Nevertheless, NLRP3 inflammasome is involved in the induction of obesity 213 and insulin resistance (135), conditions linked to aging and risk factors for brain disease. 214
PRRs and inflammasome activation in the aging brain 215
Inflamm-aging and immune senescence substantially affect the CNS (31). The low-grade 216 inflammatory status of the aged CNS is associated with recruitment of leukocytes, i.e. 217 dendritic cells and T cells, including memory CD8 T cells (119, 134) . The majority of CNS 218 diseases, including age-related pathological conditions, are characterized by 219 neuroinflammatory processes (117). These pathological conditions include neurodegenerative 220 disorders (50), like AD (113), Huntington's disease (96), Parkinson's disease (PD) (68), 221 amyotrophic lateral sclerosis (ALS) (151) or multiple sclerosis (MS) (52). In addition, 222 inflammation has been identified as an important player in cognitive dysfunctions (109), 223 memory loss (64) and cerebral ischemia as well (147). A significant part of these disorders is 224 age-related. 225
Activation of PRRs and of inflammasomes is an important event in these pathologies (Table  226 2) as a non-specific neuroinflammatory event (82). Aging was shown to induce upregulation 227 of TLR1, TLR2, TLR4, TLR5 and TLR7 and downregulation of TLR9 expression in the 228 mouse brain, while TLR3, TLR6 and TLR8 remain unchanged (81). Interestingly, 229 upregulation of innate immune system-specific genes (complement genes; TLRs: TLR2, 230 TLR4, TLR5; inflammasome-associated genes: caspase-1, IL-18 and IL-1β) in the human 231 brain is more robust during normal aging than in AD (25). 232
Among cells of the CNS, microglia, the resident innate immune cells of the CNS, express the 233 most PRRs, including a complex set of TLRs (TLR1-9) (75). Activation of TLR2, TLR4 and 234 TLR9 in microglia can lead to an inflammatory response resulting in neuronal damage (122) . 235
Activation of microglial TLR2 and TLR4 receptors enhances microglial phagocytosis of 236 neurons contributing substantially to neuronal loss during brain inflammation (105). TLR2 is 237 involved in microglial activation in chronic neurodegenerative diseases such as AD and PD 238 (63). In AD, TLR2, TLR4 and other TLRs expressed in microglial cells are involved in 239 phagocytosis of amyloid-β in the early stages and contribute to neuroinflammatory responses 240 in the late stages (54). Physiological aging is associated with an increased microglial response 241 to LPS. However, in AD, TLR4 signaling is diminished contributing to the accumulation of 242 amyloid-β in the brain (55). Similarly, cultured senescent microglial cells show decreased 243 expression of TLR2 and TLR4 and reduced capacity to migrate and phagocytize (18). In 244 contrast, upregulation of TLR4 was observed in microglial cells in the forebrain of 245 postmenopausal women (126). In addition, TLR4 localized to microglia plays a role in 246 ischemic brain injury (71). 247
Microglia express several inflammasome components as well, including inflammasome-248 forming NLRs, AIM2, the adaptor protein ASC and inflammatory caspases and can secrete 249 active IL-1β through inflammasome-dependent and -independent mechanisms (16). 250
Activation of NLRP3 inflammasome in microglial cells has been shown to be involved in the 251 pathogenesis of AD (65). A proposed mechanism is that microglia phagocytize fibrillar 252 amyloid-β, leading to lysosomal damage and release of cathepsin B from damaged lysosomes 253 into the cytoplasm. Cathepsin B activates the NLRP3 inflammasome resulting in IL-1β 254 release (62). Interestingly, only microglia isolated from aged mouse brains secrete IL-1β in 255 response to fibrillar amyloid-β, while microglia isolated from young adult mouse brains do 256 not, indicating the primed state of microglial inflammasomes in aged animals (152). Age-257 associated priming of microglia can be induced by activation of the peripheral innate immune 258 system (e.g. as a result of systemic infections) and plays a central role in exaggerated 259 neuroinflammation (67). 260
In contrast to the well-accepted role of microglia in inflammatory processes of the aging 261 brain, a recent study suggests that aging-induced upregulation of PRRs in cerebellar and 262 hypothalamic brain regions does not primarily localize to microglia (11). 263
Neurons also express TLRs which may be involved in age-related pathologies (77, 108) . 264 TLR2 expression is significantly increased in PD brain neurons and is localized to α-265 synuclein positive Lewy bodies (36). Moreover, TLR signaling in sensory neurons contributes 266 to persistent pain and neuroinflammation (85). TLR2 and TLR4 expression increases in 267 cerebral cortical neurons in response to ischemia/reperfusion contributing to neurological 268 deficits (140). TLR3, on the other hand, impairs working memory and inhibits hippocampal 269 neurogenesis (107). 270
Neurons express diverse NLRs as well and are able to form functional NLRP1, NLRP3, 271 NLRC4 and AIM2 inflammasomes (4, 74, 148) . Aging-induced NLRP1 inflammasome 272 activation in hippocampal neurons was shown to be involved in cognitive impairment (90). In 273 AD, NLRP1 is upregulated in neurons (74) 
Role of PRR and inflammasome activation in cells of the BBB 284
Brain endothelial cells are critical in regulating the communication between the immune and 285 central nervous systems (6), equipped with a whole set of signaling molecules (40, 44, 150) . 286
They are the first cells of the NVU coming in contact with circulating pathogens, activated 287 immune cells and cytokines. Moreover, brain endothelial cells are essential in activating the 288 hypothalamic-pituitary-adrenal inhibitory feedback in systemic inflammation (56). The key 289 role of the BBB as a link between neuroinflammation and neurodegeneration has been 290 increasingly recognized (59, 80) . 291
Cerebral endothelial cells have been shown to express a whole set of TLRs including TLR2, 292 TLR3, TLR4, TLR6 and TLR9 (22, 101) , and these receptors have been shown to participate 293 in important signaling processes. Besides TLR4, TLR2 is the main sensor of bacterial 294 infections in brain endothelial cells (22, 76) , while TLR3 responds to double stranded RNA 295 with cytokine release (48, 83). Activation of TLR4 or TLR2/6 leads to an increased BBB 296 permeability (101, 146) . 297
Although brain endothelial TLRs have not been directly linked to physiological or 298 pathological aging so far, TLR4/MyD88/NF-κB signaling in endothelial cells of the BBB is 299 central in the regulation of both pro-and anti-inflammatory mechanisms, which have a key 300 role in aging. Moreover, oxidative stress upregulates expression of TLR2, TLR3, TLR4 and 301 TLR6 in vitro (101). In addition, ischemic stroke-induced fibrin deposition triggers TLR2 and 302 TLR4 expression and activation in the cerebral vasculature of aged rats (155). In this process, 303 both endothelial cells and pericytes are probably involved. Besides fibrin and fibrinogen, 304
Hsp60 is another potential endogenous ligand for TLR2 and TLR4 in ischemia (14). 305
Nevertheless, using preconditioning with TLR2 or TLR4 ligands, tolerance to cerebral 306 ischemia, maintenance of microvascular patency and attenuation of BBB disruption can be 307 achieved (29, 69) . In addition, increased TLR4 expression in brain endothelial cells can 308 contribute to astrocyte swelling and brain edema formation (73). 309 TLR4 can be primarily activated by PAMPs, e.g. LPS and other pathogenic components. The 310 envelope protein of MSRV (multiple sclerosis-associated retrovirus), a virus found in most 311 patients with MS, is recognized by cerebral endothelial TLR4 and induces ICAM-1 312 overexpression, production of IL-6 and IL-8 and immune cell transmigration (35). Therefore, 313 MSRV can maintain chronic inflammation through TLR4 activation. TLR4-dependent 314 activation of ICAM-1 and of the inflammatory phenotype of brain endothelial cells has been 315 proved in other studies as well (20, 78, 128) . As a consequence, endothelial TLR4 has a 316 decisive role in neuroinflammation through leukocyte recruitment into CNS (156). On the 317 other hand, cerebral endothelial cells, and not perivascular microglia, are the main targets of 318 circulating inflammatory mediators to activate brain circuits regulating release of anti-319 inflammatory glucocorticoids (56). 320
Regarding NLR expression and activation, experimental studies were mainly performed in 321 non-cerebral endothelial cells. In a recent study (100), we detected expression of several 322
NLRsincluding NOD1, NOD2, NLRC4, NLRC5, NLRP1, NLRP3, NLRP5, NLRP9, 323 NLRP10, NLRP12, NLRA and NLRXin human brain endothelial cells. We have also 324 shown that NLRP3 expression can be significantly induced by inflammatory stimuli. 325
Expression of key inflammasome components (NOD2, NLRP3 and caspase-1) along with 326 caspase-cleaved interleukins IL-1β and IL-33 can be induced by priming with LPS and 327 activation with MDP. In addition, combining priming and activation of brain endothelial 328 inflammasomes results in active IL-1β secretion. Since this is a recently described 329 mechanism, further studies are needed to understand the role of brain endothelial 330 inflammasome activation in pathological processes of the CNS, including aging-related 331 diseases. Nevertheless, NLRP3 activation has been shown to mediate endothelial senescence 332 in non-cerebral endothelial cells (136), indicating that inflammasome activation might have 333 an important role in aging and aging-related disorders, possibly both inside and outside the 334
CNS. 335
Even much less is known about the expression and role of PRRs in cerebral pericytes. 336
Besides TLR4, NOD1 and NOD2 (60, 104), we have recently shown the expression of TLR2, 337 TLR5, TLR6, TLR10, NLRC5, NLRP1-3, NLRP5, NLRP9, NLRP10 and NLRX mRNA in 338 cultured brain pericytes (106). TLR4 expressed in brain pericytes can not only respond to 339 LPS, but to HMGB1 as well (60), suggesting the role of this receptor in sterile inflammation. 340
In addition, TLR2 expression in the post-ischemic vasculature of aged rats was shown to 341 partly co-localize with the pericyte marker PDGFRβ (155) In addition, astrocytes express several NLRs and are able to activate inflammasomes. 372
Cultured cortical astrocytes express NLRP1, NLRP3, NLRC4 and AIM2, among which 373 NLRP3 mRNA is the most abundant (5). Induction of NLRP1, NLRP3 and IL-1β in both 374 neurons and astrocytes was shown to contribute to ethanol-dependent impairment in 375 neurogenesis (157). In addition, NLRP3 inflammasome activation in astrocytes might be 376 involved in the pathogenesis of PD (87). Aberrant NLRP3 activation was described in 377 glioblastoma cells (142) . However, no IL-1β or IL-18 secretion could be detected in 378 microglia-free astrocyte cultures in response to cytokine priming and the NLRP3 activators 379 ATP, nigericin, amyloid-β or α-synuclein (61). Others observed inflammasome-dependent 380 production of IL-1β in response to LPS/amyloid-β; however, in this case microglial 381 contamination was not unambiguously excluded (24). On the other hand, inflammatory 382 activation of brain endothelial cells in neurobrucellosis was shown to partly depend on IL-1β 383 secreted by both microglia and astrocytes in a TLR2-, NLRP3-and AIM2-dependent manner 384 (95). 385
Astrocytes can activate NLRC4 inflammasomes as well, and resulting IL-1β is involved in 386 enhancing amyloid-β levels in neurons. This suggests an involvement of NLRC4 387 inflammasome in astrocytes in inflammatory responses associated with AD (84). Moreover, 388 the functional NLRP2 inflammasomeconsisting of NLRP2, ASC and caspase-1was first 389 described in astrocytes. NLRP2 inflammasome in astrocytes is preassembled into a 390 multiprotein complex with the pannexin 1 channel and the P2X7 receptor, does not require 391 priming, is activated by extracellular ATP and contributes to the maturation of IL-1β and . This suggests that NLRP2similarly to NLRP3can detect DAMPs released during 393 injury. However, the role of NLRP2 inflammasome in pathological processes has not been 394 evaluated so far. 395
Conclusions and possible future directions 396
Aging and aging-related CNS pathologies are accompanied by chronic sterile inflammation 397 (inflamm-aging) which is largely determined by activation of pattern recognition receptors 398 (PRRs), like TLR2, TLR4 or NLRP3 (Figure 2) . These react to DAMPs (damage-associated 399 molecular patterns)i.e. self-molecules released upon cellular stress, tissue injury and 400 necrosiswhich accumulate during life. Due to age-dependent increase in cytokine 401 production of senescent cells, PRRs and inflammasome components can be in a primed state 402 in elderly. Therefore, inflammasome-activating signals (e.g. amyloid-β fibrils in AD or ROS 403 released upon ischemia-reoxygenation) can directly lead to cytokine (IL-1β or IL-18) release 404 and pyroptotic cell death. 405
Inflammatory reactions in the aging brain have mainly been linked to microglia and to a lower 406 extent to astrocytes and neurons. Recently, CECs and pericytes have also been shown to 407 express PRRs and to release inflammatory cytokines. Since the vasculature is largely involved 408 in aging-related disorders, inflammatory reactions of the BBB might be involved in the 409 pathomechanism of these conditions. It is our hope that further studies will elucidate the exact 410 role of cells of the cerebral vasculature in inflammatory reactions of the aging brain. In 
